Neurology · Albuquerque area, NM
Neurology studies in Albuquerque area, NM
15 recruiting studies have a site in the Albuquerque area. This page includes nearby cities such as Rio Rancho, Santa Fe.
15 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingPhase 3
A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis
Zenas BioPharma (USA), LLC
- Location
- Albuquerque, NM + 24 other US sites
- Eligibility basics
- Ages 18–60
- RecruitingPhase 3
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
Hoffmann-La Roche
- Location
- Albuquerque, NM + 67 other US sites
- Eligibility basics
- Ages 50–90
- RecruitingPhase 3
A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
Kallyope Inc.
- Location
- Albuquerque, NM + 111 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy
Vertex Pharmaceuticals Incorporated
- Location
- Albuquerque, NM + 57 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 3
A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
Novartis Pharmaceuticals
- Location
- Albuquerque, NM + 42 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingPhase 2
Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease
Lighthouse Pharmaceuticals, Inc.
- Location
- Albuquerque, NM + 36 other US sites
- Eligibility basics
- Ages 55–80
- RecruitingPhase 3
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
Hoffmann-La Roche
- Location
- Albuquerque, NM + 52 other US sites
- Eligibility basics
- Ages 50–85
- RecruitingPhase 2
A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations
Appello Pharmaceuticals, Inc.
- Location
- Albuquerque, NM + 29 other US sites
- Eligibility basics
- Ages 30–80
- RecruitingPhase 2
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
Neuron23 Inc.
- Location
- Albuquerque, NM + 43 other US sites
- Eligibility basics
- Ages 40–80
- RecruitingPhase 2/Phase 3
Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)
DiaMedica Therapeutics Inc
- Location
- Albuquerque, NM + 35 other US sites
- Eligibility basics
- Ages 18–90
- RecruitingPhase 3
Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.
Novartis Pharmaceuticals
- Location
- Albuquerque, NM + 42 other US sites
- Eligibility basics
- Ages 40–70
- RecruitingPhase 3
A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
Kallyope Inc.
- Location
- Albuquerque, NM + 111 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingHealthy volunteers
Cognitive Strategies for Optimizing Brain Health And Managing Transgenerational Vascular Risk Factors Post-Stroke
University of New Mexico
- Location
- Albuquerque, NM
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteers
Carbon Dioxide Administration and Brain Waste Clearance
Andrew Mayer
- Location
- Albuquerque, NM
- Eligibility basics
- Ages 18–82
- RecruitingHealthy volunteers
Eye Recovery Automation for Post Injury Dysfunction (iRAPID)
New Jersey Institute of Technology
- Location
- Albuquerque, NM
- Eligibility basics
- Ages 18–40
Who these studies look for
Most require a confirmed diagnosis; memory studies often ask for a study partner who knows you well to attend some visits.
Matching a page like this one never means you qualify. Each research team decides eligibility at screening.